Delivery Order SPE2DE21D0005-SPE2D625F3L66

Award Date 3/10/25
Potential Completion Date 3/13/25
Potential Value $4.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Fixed Price with Economic Price Adjustment
Place of Performance
Canton, MA 02021, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
65
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award SPE2DE21D0005|SPE2D625F90RN, valued at $2,280, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company in Canton, Massachusetts. The contract is for PURAPLY MZ 500MG, a medical supply product, with a fixed-price delivery order and an ultimate completion date of February 24, 2025. Organogenesis is a for-profit manufacturer that specializes in advanced wound care, surgical biologics, and tissue...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,118.88 fixed-price delivery order with economic price adjustment to Organogenesis Inc., a leading regenerative medicine company based in Canton, Massachusetts. The order is for PURAPLY AM (2x2) 4 SQ CM, an advanced wound care product. This order is part of Organogenesis' broader federal contract vehicles, including a $49.5 million multiple-award Indefinite Delivery Contract with DLA Troop Support Medical for wound care...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medical products headquartered in Canton, Massachusetts. The contract, valued at $3,420.00, is for the supply of PURAPLY MZ 500MG, a wound care product. The contract is a fixed-price with economic price adjustment and has a period of performance through March 6, 2025. This award is not associated with a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company. The contract, valued at $4,645.00, is for the supply of PURAPLY MZ 500MG, a regenerative wound care product. Organogenesis is a for-profit organization and a manufacturer of goods. The contract does not utilize any set-aside designations. This delivery order is part of a larger $49.5 million multiple-award Indefinite Delivery...
This federal contract award is a delivery order (SPE2DE21D0005|SPE2D625F212L) valued at $5,100.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is for the supply of PURAPLY AM XT 4.91X4.91, an advanced wound care product. Organogenesis is a leading provider of regenerative medicine solutions to federal healthcare agencies, particularly the Department of Defense (DoD) and Department...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care and surgical biologics products. The contract, valued at $8,150.00, is for the delivery of PURAPLY MZ 500MG, a wound care product. Organogenesis holds several significant Indefinite Delivery Vehicles (IDVs) with federal agencies, including a $25 million single-award Indefinite Delivery Contract...
The U.S. Defense Logistics Agency Troop Support Medical has awarded Organogenesis Inc., a leading regenerative medicine company, a $1,118.88 fixed-price delivery order contract for PURAPLY AM (2x2) 4 SQ CM wound dressings. This is not a set-aside contract. Organogenesis is a for-profit manufacturer that has been awarded numerous prime federal contracts to provide wound care products, surgical implants, and tissue regeneration solutions to government agencies, including the Department of...
This federal contract award, valued at $6,800.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine manufacturer based in Canton, Massachusetts. The contract is a delivery order for PURAPLY AM XT 4.91X4.91 wound dressings, which are used for advanced wound care. Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and the DLA, including a $25 million...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company based in Canton, Massachusetts. The $1,239.95 fixed-price contract with economic price adjustment is for the delivery of APLIGRAF, a skin substitute product. Organogenesis, a for-profit manufacturer, has an established track record of supplying specialized medical supplies, including wound care and tissue regeneration solutions, to the...
This federal contract award, valued at $1,239.95, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a for-profit manufacturer of regenerative medicine products. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA, worth $49.5 million, for wound care dressings and medical supplies. Organogenesis, headquartered in Canton, Massachusetts, specializes in advanced wound care, surgical biologics, and tissue...
  • SPE2DE21D0005
    Indefinite Delivery Contract
  • SPE2DE21D0005-SPE2D625F3L66
    Delivery Order

This federal contract award is a delivery order under contract SPE2DE21D0005|SPE2D625F3L66, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a regenerative medicine company headquartered in Canton, Massachusetts. The $4,730.00 fixed-price contract is for the supply of PURAPLY MZ 100MG, a medical product used for advanced wound care.

Organogenesis is a for-profit manufacturer that has established itself as a key supplier of specialized medical products, including skin substitutes, wound matrices, and tissue repair technologies, to federal healthcare agencies such as the Department of Veterans Affairs (VA) and DLA. This contract award is not associated with a set-aside designation, indicating Organogenesis competes as a standard commercial vendor. The company holds several significant federal Indefinite Delivery Vehicles (IDVs) with the VA and DLA, further demonstrating its strategic position in government medical procurement.

Generated 6/9/25, 9:55 AM